NEWRegulation

Zentalis Pharmaceuticals (ZNTL) Files DEF 14A for April 28 Meeting

Published on 4/28/2026

#ZNTL#SEC#DEF14A#shareholder#meeting
Zentalis Pharmaceuticals (ZNTL) Files DEF 14A for April 28 Meeting

AI Summary

Zentalis Pharmaceuticals (ZNTL) has filed a DEF 14A with the SEC ahead of its shareholder meeting scheduled for April 28. The filing typically includes details about proposals and issues to be voted on by shareholders. This meeting can significantly influence corporate governance and strategic decisions within the company. The event is part of Zentalis’ ongoing efforts to engage its investors and align on future directives.

Source: Read original article (opens in new tab)

Related News

U.S. Sanctions Risk for Banks Involved with Chinese Teapot Refineries
Regulation

U.S. Sanctions Risk for Banks Involved with Chinese Teapot Refineries

Apr 29

Southern Poverty Law Center testimony request impacts political landscape
Regulation

Southern Poverty Law Center testimony request impacts political landscape

Apr 29

White House AI Guidance May Affect Anthropic (ANTH) Market Dynamics
Regulation

White House AI Guidance May Affect Anthropic (ANTH) Market Dynamics

Apr 29

Purdue Pharma (PDP) Receives $5.5 Billion Sentence for Opioid Misconduct
Regulation

Purdue Pharma (PDP) Receives $5.5 Billion Sentence for Opioid Misconduct

Apr 29